Shandong Jincheng Pharmaceutical Group Co Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shandong Jincheng Pharmaceutical Group Co Ltd with three other companies in this sector in China: Porton Fine Chemicals Ltd (2016 sales of 1.33 billion Chinese Renmimbi [US$194.51 million] of which 81% was Pharmaceutical R&D Production), Henan Lingrui Pharmaceutical Co., Ltd. (1.44 billion Chinese Renmimbi [US$211.00 million] of which 99% was Health Care), and Hainan Haiyao Company Limited (1.54 billion Chinese Renmimbi [US$226.36 million] of which 68% was BPC).

Sales Analysis. During the year ended December of 2016, sales at Shandong Jincheng Pharmaceutical Group Co Ltd were 1.42 billion Chinese Renmimbi (US$208.27 million). This is an increase of 20.6% versus 2015, when the company's sales were 1.18 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shandong Jincheng Pharmaceutical Group Co Ltd (and since 2011, sales have increased a total of 80%).